It is through the Programme Accès-recherche Dr. André-Robidoux that new regional hospitals are joining the Group, thus allowing their patients to participate in research protocols while staying close to their loved ones.
Susan McPeak, Co-Founder
Ultimately, we aim to gather 20 member hospitals within our consortium. This expansion will enhance access to clinical studies for patients, particularly those living outside major urban centers.
The rollout of the Programme Accès-recherche Dr André-Robidoux is underway and follows a structured process overseen by the scientific committee and the Group’s board of directors.
Since 2023, this Program is funded through a $2.5 million donation over five years from Breast Cancer Canada.
Hospital centers or researchers wishing to join the Group can do so by emailing info@mcpeaksirois.org
by directly contacting one of the researchers on our scientific committee.
Améliorer la lutte contre le cancer du sein en augmentant l’accès et la participation aux protocoles de recherche clinique.
Dans le but d’alléger le texte, patientes est utilisée au féminin puisque le cancer du sein touche majoritairement des femmes.
Conception et design site Web | Cobbox
Vous recevez des informations pertinentes sur la recherche clinique en cancer du sein ainsi que des nouvelles quant aux événements grand public que nous organisons.